Concepedia

Danielle Potter

DP

Statistics

Publications

11

Citations

597

H-Index

11

Active since

2012

Affiliations

AstraZeneca (United States)(Current)

American Society of Clinical Oncology

Universidad de Sevilla

AstraZeneca (United Kingdom)

Danielle Potter is an author at AstraZeneca (United States) specializing in pharmacy, antimicrobial resistance, and antimicrobial stewardship.

Publications per year

2012–2022

11

Publications

11

Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003–2006

Peter P. Tóth, Danielle Potter, Eileen E. Ming · Journal of clinical lipidology · 2012 · 263 citations

Life Sciences, Nutrition, Nutritional Sciences +12

Antibiotic research and development: business as usual?

Stephan Harbarth, Ursula Theuretzbacher, Judith Hackett et al. · Journal of Antimicrobial Chemotherapy · 2015 · 83 citations · Full text

Pharmacy, Pharmacoeconomics, Antimicrobial Resistance +12

Development of CancerLinQ, a Health Information Learning Platform From Multiple Electronic Health Record Systems to Support Improved Quality of Care

Danielle Potter, Raven Brothers, Andrej Kolacevski et al. · JCO Clinical Cancer Informatics · 2020 · 55 citations · Full text

Computing, Health Informatics, Oncology +9

Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active

Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock et al. · Blood Advances · 2021 · 46 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The impact of initial antibiotic treatment failure: Real-world insights in patients with complicated urinary tract infection

Sudeep Karve, Kellie Ryan, Pascale Peeters et al. · Journal of Infection · 2017 · 30 citations

Pharmacy, Infectious Diseases, Urology +16

1–5 of 11